Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
13.43
+0.05 (0.37%)
Dec 5, 2025, 4:00 PM EST - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $417.22 million as of December 5, 2025. Its market cap has increased by 245.31% in one year.
Market Cap
417.22M
Enterprise Value
304.80M
1-Year Change
245.31%
Ranking
Category
Stock Price
$13.43
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $417.22M, a decrease of -21.08%. That is a compound annual growth rate of -12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 417.22M | 265.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |